代谢

CAS号：1186486-62-3

品名：Evacetrapib;反式-4-[[(5S)-5-[[[3,5-双(三氟甲基)苯基]甲基](2-甲基-2H-四氮唑-5-基)氨基]-2,3,4,5-四氢-7,9-二甲基-1H-1-苯并氮杂卓-1-基]甲基]环己烷羧酸Evacetrapib

中文别名：反式-4-[[(5S)-5-[[[3,5-双(三氟甲基)苯基]甲基](2-甲基-2H-四氮唑-5-基)氨基]-2,3,4,5-四氢-7,9-二甲基-1H-1-苯并氮杂卓-1-基]甲基]环己烷羧酸;

英文别名：LY2484595;trans-4-[[(5S)-5-[[[3,5-Bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]cyclohexanecarboxylicacid;4-[[(5S)-5-[[3,5-bis(trifluoromethyl)phenyl]methyl-(2-methyltetrazol-5-yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1-benzazepin-1-yl]methyl]cyclohexane-1-carboxylicacid;

分子式：C31H36F6N6O2

分子量：638.647

精确质量：638.28

Psa：87.38

UNII号：51XWV9K850

密度：1.40

简介：EvacetrapibwasadrugunderdevelopmentbyEliLilly&Company(investigationalnameLY2484595)thatinhibitscholesterylestertransferprotein(CETP),whichtransfersandtherebyincreaseshigh-densitylipoproteinandlowerslow-densitylipoprotein(CETPinhibitor].Itisthoughtthatmodifyinglipoproteinlevelsmodifiestheriskofcardiovasculardisease.ThefirstCETPinhibitor,torcetrapib,wasunsuccessfulbecauseitincreasedlevelsofthehormonealdosteroneandincreasedbloodpressure,whichledtoexcesscardiaceventswhenitwasstudied.Evacetrapibdoesnothavethesameeffect.WhenstudiedinasmallclinicaltrialinpeoplewithelevatedLDLandlowHDL,significantimprovementswerenotedintheirlipidprofile.

代谢

CAS号：171596-29-5

品名：他达那非Tildenafil

中文别名：西力士;他地那非;

英文别名：Cialis;(6R,12aR)-6-(benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12atetrahydropyrazino[1',2':1,6]pyrido[3,4b]indole1,4(6H,7H)-dione;(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]\r\npyrido[3,4-b]indole-1,4-dione;

分子式：C22H19N3O4

分子量：389.404

精确质量：389.138

Psa：74.87

MDL号：MFCD07771966

外观与性状：灰白色水晶般的固体

密度：1.51 g/cm3

沸点：679.1ºC at 760 mmHg

熔点：298-300ºC

闪点：364.5ºC

折射率：1.705

蒸汽压：5.29E-13mmHg at 25°C

简介：TadalafilisaPDE5inhibitormarketedinpillformfortreatingerectiledysfunction(ED)underthenameCialis,andunderthenameAdcircaforthetreatmentofpulmonaryarterialhypertension.InOctober2011theU.S.FoodandDrugAdministration(FDA)approvedCialisfortreatingthesignsandsymptomsofbenignprostatichyperplasia(BPH)aswellasacombinationofBPHanderectiledysfunction(ED)whentheconditionscoincide.ItinitiallywasdevelopedbythebiotechnologycompanyICOS,andthenagaindevelopedandmarketedworld-widebyLillyICOS,LLC,thejointventureofICOSCorporationandEliLillyandCompany.Cialistablets,in2.5mg,5mg,10mg,and20mgdoses,areyellow,film-coated,andalmond-shaped.Theapproveddoseforpulmonaryarterialhypertensionis40mg(two20-mgtablets)oncedaily.

用途：磷酸二酯酶5抑制剂,用于治疗男性勃起功能障碍。

代谢

CAS号：238750-77-1

品名：托舍多特Tosedostat

中文别名：ALPHA-[[(2R)-2-[(1S)-1-羟基-2-(羟基氨基)-2-氧代乙基]-4-甲基-1-氧代戊基]氨基]苯乙酸环戊酯;他达拉非;

英文别名：cyclopentyl(2S)-2-[[(2R)-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl]amino]-2-phenylacetate;CHR2797-Tosedostat;CHR-2797;UNII-KZK563J2UW;

分子式：C21H30N2O6

分子量：406.473

精确质量：406.21

Psa：124.96

密度：1.24

折射率：1.566

简介：CHR-2797isanovelmetalloenzymeinhibitorthatisconvertedintoapharmacologicalactiveacidproduct(CHR-79888)insidecells.CHR-2797exertsantiproliferativeeffectsagainstarangeoftumorcelllinesinvitroandinvivoandshowsselectivityfortransformedovernontransformedcells.Itsantiproliferativeeffectsareatleast300timesmorepotentthantheprototypicalaminopeptidaseinhibitor,Bestatin.

代谢

CAS号：93957-55-2

品名：氟伐他汀钠FluvastatinSodiumSaltHydrate

中文别名：[R^^,S^^-(E)](±)-7-[3-(4-氟苯基)-1-(1-甲基乙基)-1H-吲哚-2-基]-3,5-二羟基-6庚烯酸钠;[R*,S*-(E)]-(+/-)-7-[3-(4-氟苯基)-1-(1-甲基乙基)-1-氢-吲哚-2-基]-3,5-二羟基庚-6-烯酸钠;[3R﹡,5S﹡-(E)]-(±)-7-[3-(4-氟苯基)-1-异丙基-1H-吲哚-2-基]-3,5-二羟基-6-庚烯酸钠;

英文别名：Fluvastatinsodiumsalt;

分子式：C24H25FNNaO4

分子量：433.448

精确质量：433.167

Psa：85.52

UNII号：PYF7O1FV7F

密度：

沸点：681.8ºC at 760 mmHg

熔点：194-197ºC

闪点：366.1ºC

储存条件：Desiccate at -20ºC

海关编码：2933990090

简介：AsyntheticHMG-CoAreductaseinhibitor.Antilipemic.

用途：HMG-CoA还原酶抑制剂。

代谢

CAS号：61413-54-5

品名：咯利普兰rolipram

中文别名：(±)-Rolipram;诺普利兰;4-[3-(环戊氧基)-4-甲氧基苯基]-2-吡咯烷酮;4-[3-(环戊基氧基)-4-甲氧基苯基]-2-吡咯烷二酮;

英文别名：EINECS262-771-1;Rolipramum[Latin];Adeo;Rolipram;4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one;[3H]-Rolipram;4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone;4-(3-cyclopentyloxy-4-methoxy-phenyl)-pyrrolidin-2-one;

分子式：C16H21NO3

分子量：275.343

精确质量：275.152

Psa：47.56

MDL号：MFCD00270906

外观与性状：固体

密度：1.155 g/cm3

沸点：472.7ºC at 760 mmHg

熔点：127-133ºC

闪点：239.7ºC

折射率：1.552

储存条件：0-6ºC

安全说明：S26; S36

危险类别码：R36/37/38

海关编码：2933790090

危险品运输编码：UN 3249

危险类别：6.1(b)

包装等级：III

危险品标志：Xi

简介：Rolipramisaselectivephosphodiesterase-4inhibitordiscoveredanddevelopedbyScheringAGasapotentialantidepressantdrugintheearly1990s.Itservedasaprototypemoleculeforseveralcompanies'drugdiscoveryanddevelopmentefforts.:668ffRolipramwasdiscontinuedafterclinicaltrialsshowedthatitstherapeuticwindowwastoonarrow;itcouldnotbedosedathighenoughlevelstobeeffectivewithoutcausingsignificantgastrointestinalsideeffects.:668;Rolipramhasseveralactivitiesthatmakeitacontinuingfocusforresearch.Theetiologyofmanyneurodegenerativediseasesinvolvesmisfoldedandclumpedproteinswhichaccumulateinthebrain.Cellshaveamechanismtodisposeofsuchproteinscalledtheproteasome.However,inAlzheimer'sdiseaseandsomeotherconditionstheactivityoftheseproteasomesisimpairedleadingtoabuildupoftoxicaggregates.Researchinmicesuggeststhatrolipramhastheabilitytorampuptheactivityofproteasomesandreducetheburdenoftheseaggregates.Preliminaryevidencesuggeststhatthiscanimprovespatialmemoryinmiceengineeredtohaveaggregatebuild-up.Itcontinuestobeusedinresearchasawell-characterizedPDE4inhibitor.:669IthasbeenusedinstudiestounderstandwhetherPDE4inhibitioncouldbeusefulinautoimmunediseases,Alzheimer'sdisease,cognitiveenhancement,spinalcordinjury,andrespiratorydiseaseslikeasthmaandCOPD.

代谢

CAS号：171599-83-0

品名：枸橼酸西地那非sildenafilcitrate

中文别名：西地那非柠檬酸盐;拘橼酸西地那非;

英文别名：5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one,2-hydroxypropane-1,2,3-tricarboxylicacid;Viagra,Revatio;1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d;SildenafilCitrate;Sildenafilcitrate;Sildenafilcitratesalt;

分子式：C28H38N6O11S

分子量：666.7

精确质量：666.232

Psa：253.93

MDL号：MFCD09026931

外观与性状：白色固体

密度：1.447g/cm3

沸点：672.4ºC at 760 mmHg

熔点：187-189ºC

闪点：360.5ºC

折射率：1.683

蒸汽压：0mmHg at 25°C

危险类别码：R36/37/38

海关编码：2935009090

简介：Anorallyactiveselectivetype5cGMPphosphodiesteraseinhibitor.

代谢

CAS号：875446-37-0

品名：安塞曲匹Anacetrapib

中文别名：安塞曲匹

英文别名：MK-0859;UNII-P7T269PR6S;(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-2-methoxy-5-propan-2-ylphenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-1,3-oxazolidin-2-one;

分子式：C30H25F10NO3

分子量：637.508

精确质量：637.167

Psa：38.77

UNII号：P7T269PR6S

密度：

简介：Anacetrapib(USAN,pINN;codenamedMK-0859,Merck)isaCETPinhibitorbeingdevelopedtotreathypercholesterolemia(elevatedcholesterollevels)andpreventcardiovasculardisease.

代谢

CAS号：193275-84-2

品名：洛那法尼LONAFARNIB

中文别名：克利贝特.环已双妥明;克利贝特;4-[2-[4-[(11R)-3,10-二溴-8-氯-6,11-二氢-5H-苯并[5,6]环庚并[1,2-b]吡啶-11-基]-1-哌啶基]-2-氧代乙基]-1-哌啶甲酰胺;

英文别名：1-PiperidinecarboxaMide,4-[2-[4-[(11R)-3,10-dibroMo-8-chloro-6;4-{2-[4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl]-2-oxo-ethyl}-piperidine-1-carboxylicacidamide;4-{2-[4-(3,10-dibromo-8-chloro-6,ll-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl]-2-oxo-ethyl}-piperidine-1-carboxylicacidamide;4-[2-[4-[(11R)-3,10-DibroMo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]-1-piperidinyl]-2-oxoethyl]-1;[14C]-Lonafarnib;LonafarMib;Sarasar;Lonafarnib[usan];(+)-4-[2-[4-(8-chloro-3,10-dibromo-6,11-dihydro-5H-benzo-[5,6]cyclohepta[1,2-b]-pyridin-11(R)-yl)-1-piperidinyl]-2-oxo-ethyt]-1-piperidinecarboxamide;

分子式：C27H31Br2ClN4O2

分子量：638.822

精确质量：636.05

Psa：79.53

密度：1.536

沸点：710.4ºC at 760mmHg

闪点：383.5ºC

信号词：Warning

危险性防范说明：P305 + P351 + P338

危险标志：GHS07

危险性描述：H315; H319; H335

简介：Lonafarnibisafarnesyltransferaseinhibitor(FTI)thatisbeinginvestigatedinahumanclinicaltrialasapotentialtreatmentforprogeria.

代谢

CAS号：1109276-89-2

品名：PF-04620110;反式-4-[4-(4-氨基-7,8-二氢-5-氧代嘧啶并[5,4-f][1,4]氧氮杂卓-6(5H)-基)苯基]环己烷乙酸2-[4-[4-(4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6-yl)phenyl]cyclohexyl]aceticacid

中文别名：PF-04620110;反式-4-[4-(4-氨基-7,8-二氢-5-氧代嘧啶并[5,4-f][1,4]氧氮杂卓-6(5H)-基)苯基]环己烷乙酸

英文别名：CS-0370;

分子式：C21H24N4O4

分子量：396.44

精确质量：396.18

Psa：118.64

MDL号：MFCD19443642

密度：1.3±0.1g/cm3

沸点：701.9±60.0°Cat760mmHg

闪点：378.3±32.9°C

折射率：1.623

储存条件：roomtemp

蒸汽压：0.0±2.3mmHgat25°C

海关编码：2934999090

简介：PF04620110isanorally-active,inhibitorthathasselectivitytowardsneutral-diglycerideacyltransferase-1(DGAT-1).

代谢

CAS号：1292799-56-4

品名：苏木精Quinoline,2-​[[4-​[1-​(methyl-​11C)​-​4-​(4-​pyridinyl)​-​1H-​pyrazol-​3-​yl]​phenoxy]​methyl]​-

中文别名：苏木精

英文别名：2-((4-(1-methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)quinoline;2-((4-(1-(methyl-11c)-4-(4-pyridinyl)-1h-pyrazol-3-yl)phenoxy)methyl)quinoline;

分子式：C25H20N4O

分子量：392.453

精确质量：392.164

Psa：52.83

密度：

简介：PF-2545920isadrugdevelopedbyPfizerforthetreatmentofschizophrenia.ItactsasaphosphodiesteraseinhibitorselectiveforthePDE10Asubtype.ThePDE10Aenzymeisexpressedprimarilyinthebrain,mostlyinthestriatum,nucleusaccumbensandolfactorytubercle,andisthoughttobeparticularlyimportantinregulatingtheactivityofdopamine-sensitivemediumspinyneuronsinthestriatumwhichareknowntobetargetsofconventionalantipsychoticdrugs.OlderPDE10Ainhibitorssuchaspapaverinehavebeenshowntoproduceantipsychoticeffectsinanimalmodels,andmorepotentandselectivePDE10Ainhibitorsareacurrentareaofresearchfornovelantipsychoticdrugswhichactthroughadifferentpathwaytoconventionaldopamineor5HT2Aantagonistdrugsandmayhaveamorefavourablesideeffectsprofile.PF-2545920iscurrentlyoneofthefurthestadvancedPDE10AinhibitorsindevelopmentandhasprogressedthroughtoPhaseIIclinicaltrialsinhumans.